SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-012040
Filing Date
2022-06-23
Accepted
2022-06-23 16:36:32
Documents
12
Period of Report
2022-06-21
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K kura-20220621.htm   iXBRL 8-K 103699
  Complete submission text file 0000950170-22-012040.txt   229250

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kura-20220621.xsd EX-101.SCH 2486
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kura-20220621_lab.xml EX-101.LAB 17944
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kura-20220621_pre.xml EX-101.PRE 11070
6 EXTRACTED XBRL INSTANCE DOCUMENT kura-20220621_htm.xml XML 4709
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37620 | Film No.: 221035935
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences